Clinical trial

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

NCT00404313

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MK0633 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Comparator: placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE2

Conditions

Asthmaverified · MONDO: asthma

Interventions

MK0633DRUG

Comparator: placeboDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00404313 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.